Masimo Corporation (MASI)
Automate Your Wheel Strategy on MASI
With Tiblio's Option Bot, you can configure your own wheel strategy including MASI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MASI
- Rev/Share 31.7611
- Book/Share 15.0
- PB 9.4953
- Debt/Equity 0.6902
- CurrentRatio 2.8355
- ROIC -0.1149
- MktCap 7687683036.0
- FreeCF/Share 3.5574
- PFCF 40.0192
- PE -13.5076
- Debt/Assets 0.3076
- DivYield 0
- ROE -0.5914
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MASI | BofA Securities | -- | Neutral | -- | -- | Nov. 17, 2025 |
| Reiterated | MASI | Raymond James | -- | Outperform | $170 | $194 | Dec. 27, 2024 |
News
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Here's Why Masimo (MASI) is a Strong Growth Stock
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
Published: November 18, 2025 by: PRNewsWire
Sentiment: Neutral
IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring technology.
Read More
DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo
Published: November 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
DRC congratulates Knobbe Martens on a decisive jury verdict awarding its client Masimo more than $634 million in an Apple Watch patent infringement case.
Read More
3 Reasons Growth Investors Will Love Masimo (MASI)
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Masimo (MASI) Upgraded to Buy: Here's What You Should Know
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
Read More
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights
Published: October 23, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Masimo Corporation (NASDAQ: MASI) breached their fiduciary duties to shareholders. If you currently own Masimo stock and acquired shares on or before May 4, 2022, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more ab.
Read More
Bet On 5 Top-Ranked Stocks With Rising P/E
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Tap these five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are The Honest Company, Dutch Bros, AIM ImmunoTech, Masimo and Cognizant Technology Solutions.
Read More
Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2025 financial results for the period ended September 27, 2025, after the market closes on Tuesday, November 4, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and Micah Young, Chief Financial Officer. To register for the conference call and receive the dial-in number, please use the link below. Upon registering,.
Read More
Here's Why Masimo (MASI) is a Strong Growth Stock
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Read More
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Is the Options Market Predicting a Spike in Masimo Stock?
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to MASI stock based on the movements in the options market lately.
Read More
Masimo Completes Divestment of Consumer Audio Business to HARMAN
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
MASI completes sale of Sound United to HARMAN, sharpening focus on core healthcare, boosting margins, and funding buybacks.
Read More
All You Need to Know About Masimo (MASI) Rating Upgrade to Strong Buy
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Here's Why Masimo (MASI) is a Strong Growth Stock
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
Published: September 17, 2025 by: Business Wire
Sentiment: Neutral
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--A new study showed that universal surveillance monitoring with Masimo SET® pulse oximetry and Patient SafetyNet™ can yield significant cost savings.
Read More
Bet on 5 Top-Ranked Stocks With Rising P/E
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Post Holdings, Service Corporation International, TAL Education Group, Masimo and Okta.
Read More
Here is Why Growth Investors Should Buy Masimo (MASI) Now
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Read More
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Masimo (MASI)
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
Read More
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Published: June 04, 2025 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this.
Read More
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.
Read More
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Read More
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.
Read More
About Masimo Corporation (MASI)
- IPO Date 2007-08-08
- Website https://www.masimo.com
- Industry Medical - Instruments & Supplies
- CEO Catherine M. Szyman
- Employees 3600